Related Experiment Video
Updated: Feb 18, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Targeting protein quality control pathways in breast cancer
Sara Sannino, Jeffrey L Brodsky1
1Department of Biological Sciences, University of Pittsburgh, A320 Langley Hall, 4249 Fifth Ave, Pittsburgh, PA, 15260, USA. jbrodsky@pitt.edu.
Cancer cells rely on protein folding and stress response pathways for survival. Targeting molecular chaperones, protein degradation, and autophagy offers potential breast cancer treatments and strategies against drug resistance.
Area of Science:
- Molecular biology
- Cancer research
- Cellular stress response
Background:
- Protein homeostasis is crucial for cancer cell survival.
- Cancer cells exploit molecular chaperones and stress response pathways to cope with damage.
- Key pathways include protein folding, degradation (ubiquitin-proteasome, autophagy), and unfolded protein response.
Purpose of the Study:
- To explore the intricate links between breast cancer progression and cellular stress response mechanisms.
- To investigate the role of protein homeostasis pathways in cancer cell survival and drug resistance.
- To identify potential therapeutic targets within these pathways for breast cancer treatment.
Main Methods:
- Review of existing literature on protein folding, stress response, and cancer biology.
- Analysis of the role of molecular chaperones, ubiquitin-proteasome system, and autophagy in breast cancer.
- Examination of therapeutic strategies targeting these pathways.
Main Results:
- Overexpression of molecular chaperones aids cancer cell survival under stress.
- Protein degradation pathways (ubiquitin-proteasome, autophagy) are critical for managing misfolded proteins in cancer.
- Stress response pathways are frequently activated and are validated anti-cancer targets.
Conclusions:
- Molecular chaperones, protein degradation, and stress response pathways are integral to breast cancer survival and progression.
- Targeting these pathways presents a promising avenue for novel breast cancer therapies.
- Understanding these mechanisms is vital for overcoming drug resistance and preventing relapse.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
PI3K/mTOR/AKT Signaling Pathway
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

